Literature DB >> 6210909

Multiple low-dose streptozotocin-induced hyperglycemia and insulitis in C57BL mice: influence of inbred background, sex, and thymus.

E H Leiter.   

Abstract

Insulin-dependent diabetes induced in susceptible strains of mice by multiple, low-dose streptozotocin treatment has been proposed to entail a thymus-dependent, autoimmune destruction of beta cells. In this study, thymectomized and genetically athymic mice have been tested for susceptibility to streptozotocin. Thymectomy was performed on newborn (day 1) to 3-day-old C57BL/KsJ mice. At 8 wk of age, thymectomized and sham-operated mice of both sexes were tested for susceptibility to diabetes induction by multiple, low-dose streptozotocin treatment (35 mg/kg of body weight per day for 6 consecutive days). Thymectomy failed to block susceptibility of males to induction of severe hyperglycemia. Beta cell necrosis and inflammatory cell infiltrates (insulitis) were consistent histopathological features. In general, females-both thymus-intact and thymectomized-were less susceptible than males to streptozotocin-induced hyperglycemia, and females exhibited an equally severe insulitis by experimental day 14; thus, the detection of an underlying insulitis did not predict the development of a more severe hyperglycemia because most streptozotocin-treated females at experimental day 35 continued to show only a modest hyperglycemia (about 200 mg/dl) compared to males (>400 mg/dl). That streptozotocin-induced hyperglycemia could occur in the absence of an intact thymus was further demonstrated in genetically athymic C57BL/6J NIcrOu nu/nu males and thymus-intact +/? littermate controls. C57BL/6J mice were resistant to streptozotocin-induced insulitis. This study shows that the presence of insulitis does not necessarily presage onset of severe hyperglycemia (e.g., C57BL/KsJ females), and conversely, the presence of severe hyperglycemia after low-dose streptozotocin treatment is not necessarily diagnostic of an underlying insulitis (e.g., C57BL/6J +/? and nu/nu males). These data stress the need for caution in the interpretation of studies of streptozotocin-insulitis sensitivities of nude mice.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6210909      PMCID: PMC345800          DOI: 10.1073/pnas.79.2.630

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Complete protection from low-dose streptozotocin-induced diabetes in mice.

Authors:  A A Rossini; R M Williams; M C Appel; A A Like
Journal:  Nature       Date:  1978-11-09       Impact factor: 49.962

2.  Immunological aspects of diabetes mellitus.

Authors:  W J Irvine
Journal:  Adv Exp Med Biol       Date:  1979       Impact factor: 2.622

3.  The spontaneously diabetic Wistar rat (the "BB" rat). Studies prior to and during development of the overt syndrome.

Authors:  A F Nakhooda; A A Like; C I Chappel; C N Wei; E B Marliss
Journal:  Diabetologia       Date:  1978-03       Impact factor: 10.122

4.  Hyperinsulinemia in pre-weaning diabetes (db) mice.

Authors:  D L Coleman; K P Hummel
Journal:  Diabetologia       Date:  1974-11       Impact factor: 10.122

5.  Pathologic anatomy of the pancreas in juvenile diabetes mellitus.

Authors:  W Gepts
Journal:  Diabetes       Date:  1965-10       Impact factor: 9.461

6.  Influence of nicotinamide and pyridine nucleotides on streptozotocin and alloxan-induced pancreatic B cell cytotoxicity.

Authors:  S S Lazarus; S H Shapiro
Journal:  Diabetes       Date:  1973-07       Impact factor: 9.461

7.  Sex differences in the multiple-dose streptozotocin model of diabetes.

Authors:  A A Rossini; R M Williams; M C Appel; A A Like
Journal:  Endocrinology       Date:  1978-10       Impact factor: 4.736

8.  Is the diabetogenic effect of streptozotocin in part thymus-dependent?

Authors:  K Buschard; J Rygaard
Journal:  Acta Pathol Microbiol Scand C       Date:  1978-02

9.  Genetic influence of the streptozotocin-induced insulitis and hyperglycemia.

Authors:  A A Rossini; M C Appel; R M Williams; A A Like
Journal:  Diabetes       Date:  1977-10       Impact factor: 9.461

10.  Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus.

Authors:  A A Like; A A Rossini
Journal:  Science       Date:  1976-07-30       Impact factor: 47.728

View more
  68 in total

1.  Calcium insufficiency accelerates type 1 diabetes in vitamin D receptor-deficient nonobese diabetic (NOD) mice.

Authors:  John P Driver; Deanna J Lamont; Conny Gysemans; Chantal Mathieu; David V Serreze
Journal:  Endocrinology       Date:  2011-09-27       Impact factor: 4.736

2.  CD18 deficiency protects against multiple low-dose streptozotocin-induced diabetes.

Authors:  Shayne C Barlow; Will Langston; Kametra M Matthews; John H Chidlow; Christopher G Kevil
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

3.  PTEN-induced partial epithelial-mesenchymal transition drives diabetic kidney disease.

Authors:  Yajuan Li; Qingsong Hu; Chunlai Li; Ke Liang; Yu Xiang; Heidi Hsiao; Tina K Nguyen; Peter K Park; Sergey D Egranov; Chandrashekar R Ambati; Nagireddy Putluri; David H Hawke; Leng Han; Mien-Chie Hung; Farhad R Danesh; Liuqing Yang; Chunru Lin
Journal:  J Clin Invest       Date:  2019-02-11       Impact factor: 14.808

4.  Activation of AKT by O-linked N-acetylglucosamine induces vascular calcification in diabetes mellitus.

Authors:  Jack M Heath; Yong Sun; Kaiyu Yuan; Wayne E Bradley; Silvio Litovsky; Louis J Dell'Italia; John C Chatham; Hui Wu; Yabing Chen
Journal:  Circ Res       Date:  2014-02-13       Impact factor: 17.367

5.  Susceptibility to db gene and streptozotocin-induced diabetes in C57BL mice: control by gender-associated, MHC-unlinked traits.

Authors:  E H Leiter; P H Le; D L Coleman
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

6.  Multiple low-dose streptozotocin-induced diabetes in the mouse. Evidence for stimulation of a cytotoxic cellular immune response against an insulin-producing beta cell line.

Authors:  R C McEvoy; J Andersson; S Sandler; C Hellerström
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

7.  Early hepatic insulin resistance precedes the onset of diabetes in obese C57BLKS-db/db mice.

Authors:  Richard C Davis; Lawrence W Castellani; Maryam Hosseini; Osnat Ben-Zeev; Hui Z Mao; Michael M Weinstein; Dae Young Jung; John Y Jun; Jason K Kim; Aldons J Lusis; Miklós Péterfy
Journal:  Diabetes       Date:  2010-04-14       Impact factor: 9.461

8.  High pancreatic n-3 fatty acids prevent STZ-induced diabetes in fat-1 mice: inflammatory pathway inhibition.

Authors:  Jérôme Bellenger; Sandrine Bellenger; Amandine Bataille; Karen A Massey; Anna Nicolaou; Mickaël Rialland; Christian Tessier; Jing X Kang; Michel Narce
Journal:  Diabetes       Date:  2011-02-17       Impact factor: 9.461

9.  The partial protective effect of the hydroxyl radical scavenger dimethyl urea on streptozotocin-induced diabetes in the mouse in vivo and in vitro.

Authors:  S Sandler; A Andersson
Journal:  Diabetologia       Date:  1982-10       Impact factor: 10.122

10.  Transfer of hematopoietic stem cells encoding autoantigen prevents autoimmune diabetes.

Authors:  Raymond J Steptoe; Janine M Ritchie; Leonard C Harrison
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.